CAS RN: 4383-25-9
N-Benzylcyclohexanamine
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250905
250mg / 1g / 5g / 25g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4383-25-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>95%
0
Out of Stock
Shanghai
Inquiry
4383-25-9 / N-benzylcyclohexanamine
Standard CAS: 4383-25-9
Multi CAS: No
Basic Information
copy
CAS
4383-25-9 copy
Multi CAS
No copy
Molecular Formula
C13H19N copy
Molecular Weight
189.300000 copy
Exact Mass
189.151750 copy
InChI
InChI=1S/C13H19N/c1-3-7-12(8-4-1)11-14-13-9-5-2-6-10-13/h1,3-4,7-8,13-14H,2,5-6,9-11H2 copy
InChIKey
IYWYMFZAZUYNLC-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.54 copy
Rotatable bonds
3 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
60.15 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
3.11 copy
MLOGP
2.73 copy
XLogP3
3.1 copy
Consensus LogP
2.98 copy
Log S (ESOL)
-3.09 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.36 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.83 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.67 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy